Fecal microbiota transplantation: Where is it leading?

Gastroenterology and Hepatology

Volumn 10, Issue 5, 2014, Pages 307-309

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BODY MASS; CLOSTRIDIUM DIFFICILE INFECTION; DRUG APPROVAL; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; FOOD ALLERGY; HUMAN; INTESTINE FLORA; PATIENT EDUCATION; PATIENT SAFETY; RISK; TRANSPLANTATION;

EID: 84902507483     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Zhang F, Luo W, Shi Y, Fan Z, Ji G. Should we standardize the 1,700-year-old fecal microbiota transplantation? Am J Gastroenterol. 2012;107(11):1755; author reply 1755-1756.
2. Guidance for industry: enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies. U.S. Department of Health and Human Services Food and Drug Administration. http://www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/ucm361379.htm. Accessed March 11, 2014.
3. Bakken JS, Borody T, Brandt LJ, et al; Fecal Microbiota Transplantation Workgroup. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol. 2011;9(12):1044-1049.
4. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012;107(5):761-767.
5. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science. 2005;308(5728):1635-1638. (Pubitemid 40807514)
6. Draft guidance for industry: enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies. U.S. Department of Health and Human Services Food and Drug Administration. http://www.fda.gov/biologicsbloodvaccines/ guidancecomplianceregulatoryinformation/guidances/vaccines/ucm387023.htm. Accessed March 21, 2014.